Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 68084-697

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68084-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp69701

BuPROPion Hydrochloride 150 mg tablet, extended-release, film-coated oral tablet. One side shows the imprint 'WPI 8 5 8' while the other side is plain. This is a white, round tablet manufactured by American Health Packaging.*

FDA Label Image

Ahp70825

BuPROPion Hydrochloride extended-release film-coated tablets, 100 mg or 150 mg strength, oral dosage form. One tablet side shows the imprint 'WPI 839'; the other side is plain and unmarked. The tablets are round, white, and unscored. Labeled by American Health Packaging.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of bupropion hydrochloride, showing a chlorophenyl ring with connected chemical groups including NHC(CH3)3 and COCH3 moieties.*

FDA Label Image

100 mg Bupropion HCl Er Tablets Carton (100 mg Bupropion HCl Er Tablets Carton)

Label for BuPROPion HCl Extended-Release Tablets, USP (SR), 100 mg strength. The label indicates a package of 100 tablets (10 blister packs of 10 tablets each), with directions for twice-a-day dosing after initial titration. Distributed by American Health Packaging, Columbus, Ohio. Includes warnings, pharmacist instructions, and a QR code for Medication Guide and Prescribing Information.*

FDA Label Image

100 mg Bupropion HCl Er Tablet Blister (100 mg Bupropion HCl Er Tablet Blister)

Label image for BuPROPion Hydrochloride 100 mg extended-release film-coated tablets, oral dosage form. The label states Twice-A-Day BuPROPion HCl Extended-Release Tablet, USP (SR) with the strength 100 mg prominently displayed. It also includes placeholders for lot and expiration dates. The labeler is American Health Packaging.*

FDA Label Image

150 mg Bupropion HCl Er Tablets Carton (150 mg Bupropion HCl Er Tablets Carton)

Label for BuPROPion HCl Extended-Release Tablets, USP (SR) 150 mg by American Health Packaging. The oral tablet product is packaged in quantities of 30 tablets (5 x 6) and labeled for twice-a-day use after initial titration. The label includes NDC 68084-708-25, barcode, QR code for medication guide and prescribing information, storage instructions, and a warning about not using in combination with Zyban or other bupropion-containing medicines.*

FDA Label Image

150 mg Bupropion HCl Er Tablet Blister (150 mg Bupropion HCl Er Tablet Blister)

The image shows multiple identical label panels for BuPROPion Hydrochloride extended-release tablets, 150 mg strength. Each label includes the proprietary name Twice-A-Day BuPROPion HCl Extended-Release Tablet, USP (SR), with lot number and expiration date placeholders. The labels also display a barcode and the labeler name American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.